SINA DRUG LLC - ONCO 360: MODEYSO (DORADVIPRONE) MEDICATION DOS: NOVEMBER 12, 2025 THRU SEPTEMBER 30, 2026 **ORDERS PLACED AS NECESSARY BY PROVIDER** FUNDS WILL BE OBLIGATED THROUGH A MOD UPON THE OFFICIAL ANNOUNCEMENT OF THE CR DATE

On Feb 18, 2026, Department of Justice obligated $115,700.42 to SINA DRUG LLC for onco 360: modeyso (doradviprone) medication dos: november 12, 2025 thru september 30, 2026 **orders placed as necessary by provider** funds will be obligated through a mod upon the official announcem…. The award is classified under NAICS 524292 — PHARMACY BENEFIT MANAGEMENT AND OTHER THIRD PARTY ADMINISTRATION OF INSURANCE AND PENSION FUNDS and issued as a firm fixed price contract. Competition extent: competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in LOUISVILLE, KY. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining. This award is one of several similar procurements from Department of Justice under NAICS 524292 — related awards are listed below.